Joseph Leveque, M.D. has been appointed U.S. chief medical officer at EMD Serono, the U.S. biopharmaceutical business of Merck KGaA. Dr. Leveque will be responsible for working with the regulatory, medical and development teams to enhance EMD Serono’s clinical presence in the U.S. and to drive key medical initiatives.   Dr. Leveque has more than 20 years of experience in the areas of strategic leadership, advancing medical and clinical programs, as well as life cycle management. Most rec...